User Preferences in a Carrageenan-Based Vaginal Drug Delivery System

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Li, Bangde ^a   Zaveri, Toral ^a   Ziegler, Gregory R ^a   Hayes, John E ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; MICROBICIDE; POTASSIUM CHLORIDE;

ARTICLE; ATTITUDE TO HEALTH; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PREFERENCE; DRUG SCREENING; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; OUTCOME ASSESSMENT; SEXUAL INTERCOURSE; VISUAL ANALOG SCALE;

ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS, LOCAL; CARRAGEENAN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; VAGINA;

EID: 84872854965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054975     Document Type: Article

References (39)

1. UNAIDS (2011) Epidemic update and health sector progress towards Universal Access. Progress Report 2011.
2. Piot P, (2001) A gendered epidemic: women and the risks and burdens of HIV. J Am Med Womens Assoc 56: 90-91.
3. Lowndes C, Alary M, Belleau M, Bosu W, Kintin D, et al. (2008) West Africa HIV/AIDS Epidemiology and Response Synthesis. Characterisation of the HIV epidemic and response in West Africa: Implications for prevention.
4. CDC (2012) HIV in the United States: At A Glance.
5. Mason TH, Foster SE, Finlinson HA, Morrow KM, Rosen R, et al. (2003) Perspectives related to the potential use of vaginal microbicides among drug-involved women: focus groups in three cities in the United States and Puerto Rico. AIDS Behav 7: 339-351.
6. CDC (1993) Update: Barrier Protection Against HIV Infection and Other Sexually Transmitted Diseases.
7. Stone A, (2002) Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat Rev Drug Discov 1: 977-985.
8. Darroch JE, Frost JJ, (1999) Women's interest in vaginal microbicides. Fam Plann Perspect 31: 16-23.
9. Han L, Lv F, Xu P, Zhang GL, Juniper NS, et al. (2009) Microbicide Acceptability among Female Sex Workers in Beijing, China: Results from a Pilot Study. Journal of Womens Health 18: 1377-1384.
10. Frank ML, Poindexter AN, Cox CA, Bateman L, (1995) A cross-sectional survey of condom use in conjunction with other contraceptive methods. Women Health 23: 31-46.
11. Beksinska ME, Rees VH, McIntyre JA, Wilkinson D, (2001) Acceptability of the female condom in different groups of women in South Africa-a multicentred study to inform the national female condom introductory strategy. S Afr Med J 91: 672-678.
12. UNAIDS (2007) A joint assessment of HIV/AIDS prevention, treatment and care in China.
13. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.
14. Severy LJ, Tolley E, Woodsong C, Guest G, (2005) A framework for examining the sustained acceptability of microbicides. AIDS and Behavior 9: 121-131.
15. van de Wijgert J, Coggins C, (2002) Microbicides to prevent heterosexual transmission of HIV: ten years down the road. BETA 15: 23-28.
16. AMD (2009) Microbicide Pipeline Summary Report.
17. Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, et al. (2010) Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral Research 88: S19-S29.
18. Tasoglu S, Park SC, Peters JJ, Katz DF, Szeri AJ, (2011) The consequences of yield stress on deployment of a non-Newtonian anti-HIV microbicide gel. J Nonnewton Fluid Mech 166: 1116-1122.
19. Menon S, Izquierdo A, Rosen M, Hummel A, Barnhart K, (2007) The effect of ambulation on vaginal distribution of miconazole nitrate (1200 mg). J Womens Health (Larchmt) 16: 703-706.
20. Hardy E, de Padua KS, Hebling EM, Osis MJ, Zaneveld LJ, (2003) Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products. Contraception 67: 391-395.
21. Kilmarx PH, van de Wijgert JHHM, Chaikummao S, Jones HE, Limpakarnjanarat K, et al. (2006) Safety and acceptability of the candidate microbicide Carraguard in Thai women: Findings from a phase II clinical trial. J Acquir Immune Defic Syndr 43: 327-334.
22. Morrow KM, Hendrix C, (2010) Clinical evaluation of microbicide formulations. Antiviral Res 88: S40-S46.
23. Elias C, Coggins C, (2001) Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? Journal of Womens Health & Gender-Based Medicine 10: 163-173.
24. Padian NS, McCoy SI, Balkus JE, Wasserheit JN, (2010) Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 24: 621-635.
25. Nel AM, Mitchnick LB, Risha P, Muungo LTM, Norick PM, (2011) Acceptability of Vaginal Film, Soft-Gel Capsule, and Tablet as Potential Microbicide Delivery Methods Among African Women. Journal of Womens Health 20: 1207-1214.
26. Mahan ED, Morrow KM, Hayes JE, (2011) Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development. Contraception 84: 184-193.
27. Hira SK, Spruyt AB, Feldblum PJ, Sunkutu MR, Glover LH, et al. (1995) Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. Am J Public Health 85: 1098-1103.
28. Hammett TM, Mason TH, Joanis CL, Foster SE, Harmon P, et al. (2000) Acceptability of formulations and application methods for vaginal microbicides among drug-involved women- Results of product trials in three cities. Sexually Transmitted Diseases 27: 119-126.
29. Zaveri T, Li B, Hayes JE, Ziegler GR (2012) Improving Carrageenan-based Vaginal Drug Delivery Systems using Consumer Acceptability XIX internatial AIDS Conference July 22-27. Washington DC, USA.
30. Morrow KM, Fava JL, Rosen RK, Christensen AL, Vargas S, et al. (2007) Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type. Health Psychology 26: 777-786.
31. Mantell JE, Myer L, Carballo-Dieguez A, Stein Z, Ramjee G, et al. (2005) Microbicide acceptability research: current approaches and future directions. Social Science & Medicine 60: 319-330.
32. Morrow KM, Ruiz MS, (2008) Assessing microbicide acceptability: A comprehensive and integrated approach. AIDS Behav 12: 272-283.
33. Tolley EE, Severy LJ, (2006) Integrating behavioral and social science research into microbicide clinical trials: Challenges and opportunities. American Journal of Public Health 96: 79-83.
34. Giguere R, Carballo-Dieguez A, Ventuneac A, Mabragana M, Dolezal C, et al. (2012) Variations in microbicide gel acceptability among young women in the USA and Puerto Rico. Culture Health & Sexuality 14: 151-166.
35. Coggins C, Blanchard K, Friedland B, (2000) Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reproductive Health Matters 8: 132-141.
36. Bentley ME, Fullem AM, Tolley EE, Kelly CW, Jogelkar N, et al. (2004) Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health 94: 1159-1164.
37. Verguet S, Holt BY, Szeri AJ (2010) Increasing the Effectiveness of Vaginal Microbicides: A Biophysical Framework to Rethink Behavioral Acceptability. Plos One 5.
38. Whitehead SJ, Kilmarx PH, Blanchard K, Manopaiboon C, Chaikummao S, et al. (2006) Acceptability of Carraguard vaginal gel use among Thai couples. AIDS 20: 2141-2148.
39. Whitehead SJ, McLean C, Chaikummao S, Braunstein S, Utaivoravit W, et al. (2011) Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand. PLoS One 6: e14831.